CLINICAL RESEARCH: DIASTOLIC DYSFUNCTION AND DIABETES MELLITUS
Diastolic dysfunction is associatedwith altered myocardial metabolism inasymptomatic normotensive patientswith well-controlled type 2 diabetes mellitus
Michaela Diamant, MD, PhD*||,*,
Hildo J. Lamb, PhD ,
Ymte Groeneveld, MD, PhD ,
Edwin L. Endert,
Jan W. A. Smit, MD, PhD*,
Jeroen J. Bax, MD, PhD ,
Johannes A. Romijn, MD, PhD*,
Albert de Roos, MD, PhD and
Jasper K. Radder, MD, PhD*
* Departments of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Radiology, Leiden University Medical Center, Leiden, The Netherlands
General Practice, Leiden University Medical Center, Leiden, The Netherlands
Cardiology, Leiden University Medical Center, Leiden, The Netherlands
|| Department of Endocrinology/Diabetes Center, VU University Medical Center, Amsterdam, The Netherlands
Manuscript received December 16, 2002;
revised manuscript received April 4, 2003,
accepted April 17, 2003.
* Reprint requests and correspondence: Dr. Michaela Diamant, Department of Endocrinology/Diabetes Center, VU University Medical Center, De Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands.
m.diamant{at}vumc.nl
OBJECTIVES: This study evaluated myocardial function in relation to high-energy phosphate (HEP) metabolism in asymptomatic patients with uncomplicated type 2 diabetes mellitus using magnetic resonance (MR) techniques.
BACKGROUND: Myocardial dysfunction may occur in patients with type 2 diabetes mellitus in the absence of coronary artery disease or left ventricular (LV) hypertrophy. The mechanisms underlying this diabetic cardiomyopathy are largely unknown, but may involve altered myocardial energy metabolism.
METHODS: We assessed myocardial systolic and diastolic function and HEP metabolism in 12 asymptomatic normotensive male patients with recently diagnosed, well-controlled type 2 diabetes and 12 controls, using MR imaging and phosphorus-31-nuclear MR spectroscopy (31P-MRS) on a 1.5 T clinical scanner; 31P-MR spectra were quantified, and myocardial HEP metabolism was expressed as phosphocreatine to adenosine-triphosphate (PCr/ATP) ratio.
RESULTS: No differences were found in LV mass and systolic function between patients and controls. However, early (E) acceleration peak, deceleration peak, peak filling rate, and transmitral early-to-late diastolic peak flow (E/A) ratio, all indexes of diastolic function, were significantly decreased in patients compared with controls (p < 0.02). In addition, myocardial PCr/ATP in patients was significantly lower than in controls (1.47 vs. 1.88, p < 0.01). Inverse associations were found between myocardial PCr/ATP and E acceleration peak, E deceleration peak, and E peak filling rate (all, p < 0.05).
CONCLUSIONS: These results indicate that altered myocardial energy metabolism may contribute to LV diastolic functional changes in patients with recently diagnosed, well-controlled and uncomplicated type 2 diabetes.
|
Abbreviations and Acronyms
| | ACR | | albumin/creatinine ratio | | ATP | | adenosine-triphosphate | | CAD | | coronary artery disease | | CK | | creatine kinase | | CVD | | cardiovascular disease | | DCM | | diabetic cardiomyopathy | | E/A | | early-to-late diastolic | | EDV | | end-diastolic volume | | ESV | | end-systolic volume | | FFA | | free fatty acids | | HEP | | high-energy phosphate | | LV | | left ventricle/ventricular | | MR | | magnetic resonance | | MRI | | magnetic resonance imaging | | PCr | | phosphocreatine | | SV | | stroke volume | | 31P-MRS | | phosphorus-31 magnetic resonance spectroscopy |
|
This article has been cited by other articles:
|
|
|
|
 
T. P. Flagg, O. Cazorla, M. S. Remedi, T. E. Haim, M. A. Tones, A. Bahinski, R. E. Numann, A. Kovacs, J. E. Schaffer, C. G. Nichols, et al.
Ca2+-Independent Alterations in Diastolic Sarcomere Length and Relaxation Kinetics in a Mouse Model of Lipotoxic Diabetic Cardiomyopathy
Circ. Res.,
January 2, 2009;
104(1):
95 - 103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. van Heerebeek and W. J. Paulus
The dialogue between diabetes and diastole
Eur J Heart Fail,
January 1, 2009;
11(1):
3 - 5.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Shearer, D. L. Severson, L. Su, L. Belardinelli, and A. K. Dhalla
Partial A1 Adenosine Receptor Agonist Regulates Cardiac Substrate Utilization in Insulin-Resistant Rats in Vivo
J. Pharmacol. Exp. Ther.,
January 1, 2009;
328(1):
306 - 311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-G. Niu and R. D. Evans
Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference
Am J Physiol Endocrinol Metab,
November 1, 2008;
295(5):
E1106 - E1116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Hammer, R. W. van der Meer, H. J. Lamb, H. H. de Boer, J. J. Bax, A. de Roos, J. A. Romijn, and J. W. A. Smit
Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus
Am J Physiol Endocrinol Metab,
September 1, 2008;
295(3):
E714 - E718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. T. Chew, G. F. Watts, T. M.E. Davis, B. G.A. Stuckey, L. J. Beilin, P. L. Thompson, V. Burke, and P. J. Currie
Hemodynamic Effects of Fenofibrate and Coenzyme Q10 in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction
Diabetes Care,
August 1, 2008;
31(8):
1502 - 1509.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. van der Meer, L. J. Rijzewijk, M. Diamant, S. Hammer, M. Schar, J. J. Bax, J. W.A. Smit, J. A. Romijn, A. de Roos, and H. J. Lamb
The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function
Eur. Heart J.,
June 2, 2008;
29(12):
1516 - 1522.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. D. Abel, S. E. Litwin, and G. Sweeney
Cardiac Remodeling in Obesity
Physiol Rev,
April 1, 2008;
88(2):
389 - 419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Hammer, R. W. van der Meer, H. J. Lamb, M. Schar, A. de Roos, J. W. A. Smit, and J. A. Romijn
Progressive Caloric Restriction Induces Dose-Dependent Changes in Myocardial Triglyceride Content and Diastolic Function in Healthy Men
J. Clin. Endocrinol. Metab.,
February 1, 2008;
93(2):
497 - 503.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Erdmann and R. G. Wilcox
Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure
Eur. Heart J.,
January 1, 2008;
29(1):
12 - 20.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Kim, G. Kewalramani, P. Puthanveetil, V. Lee, U. Kumar, D. An, A. Abrahani, and B. Rodrigues
Acute Diabetes Moderates Trafficking of Cardiac Lipoprotein Lipase Through p38 Mitogen-Activated Protein Kinase Dependent Actin Cytoskeleton Organization
Diabetes,
January 1, 2008;
57(1):
64 - 76.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. van Heerebeek, N. Hamdani, M. L. Handoko, I. Falcao-Pires, R. J. Musters, K. Kupreishvili, A. J.J. Ijsselmuiden, C. G. Schalkwijk, J. G.F. Bronzwaer, M. Diamant, et al.
Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension
Circulation,
January 1, 2008;
117(1):
43 - 51.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. Chandler, E. E. Morgan, T. A. McElfresh, T. A. Kung, J. H. Rennison, B. D. Hoit, and M. E. Young
Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1609 - H1616.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-Y. Deng, J.-P. Huang, L.-S. Lu, and L.-M. Hung
Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats
Am J Physiol Heart Circ Physiol,
August 1, 2007;
293(2):
H978 - H987.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ashrafian, M. P. Frenneaux, and L. H. Opie
Metabolic Mechanisms in Heart Failure
Circulation,
July 24, 2007;
116(4):
434 - 448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Perseghin, G. Ntali, F. De Cobelli, G. Lattuada, A. Esposito, E. Belloni, T. Canu, F. Costantino, F. Ragogna, P. Scifo, et al.
Abnormal Left Ventricular Energy Metabolism in Obese Men With Preserved Systolic and Diastolic Functions Is Associated With Insulin Resistance
Diabetes Care,
June 1, 2007;
30(6):
1520 - 1526.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. d. l. Fuentes, A. L. Brown, S. J. Mathews, A. D. Waggoner, P. F. Soto, R. J. Gropler, and V. G. Davila-Roman
Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass
Eur. Heart J.,
March 1, 2007;
28(5):
553 - 559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Avgeropoulou, A. Illmann, P.-M. Schumm-Draeger, J. Kallikazaros, and H. Von Bibra
Assessment of arterio-ventricular coupling by tissue Doppler and wave intensity in type 2 diabetes
The British Journal of Diabetes & Vascular Disease,
November 1, 2006;
6(6):
271 - 278.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol,
October 1, 2006;
291(4):
H1489 - H1506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Bertoni, D. C. Goff Jr, R. B. D'Agostino Jr, K. Liu, W. G. Hundley, J. A. Lima, J. F. Polak, M. F. Saad, M. Szklo, R. P. Tracy, et al.
Diabetic Cardiomyopathy and Subclinical Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA).
Diabetes Care,
March 1, 2006;
29(3):
588 - 594.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Valle, E. Bagolin, C. Canali, P. Giovinazzo, S. Barro, N. Aspromonte, E. Carbonieri, and L. Milani
The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients
Eur J Echocardiogr,
January 1, 2006;
7(1):
40 - 44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Perseghin, P. Fiorina, F. De Cobelli, P. Scifo, A. Esposito, T. Canu, M. Danna, C. Gremizzi, A. Secchi, L. Luzi, et al.
Cross-Sectional Assessment of the Effect of Kidney and Kidney-Pancreas Transplantation on Resting Left Ventricular Energy Metabolism in Type 1 Diabetic-Uremic Patients: A Phosphorous-31 Magnetic Resonance Spectroscopy Study
J. Am. Coll. Cardiol.,
September 20, 2005;
46(6):
1085 - 1092.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Kosmala, P. Colonna, M. Przewlocka-Kosmala, and W. Mazurek
Right Ventricular Dysfunction in Asymptomatic Diabetic Patients
Diabetes Care,
November 1, 2004;
27(11):
2736 - 2738.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.T. Chew and G.F. Watts
Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'
QJM,
August 1, 2004;
97(8):
537 - 548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Young
Diastolic Function and Type 1 Diabetes
Diabetes Care,
August 1, 2004;
27(8):
2081 - 2083.
[Full Text]
[PDF]
|
|
|
|
